Skip to main content

Table 1 Characteristics of Stage II Gastric Cancer Patients before and after PSM

From: Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research

Characteristic

Before PSM (n = 1121)

After PSM (n = 948)

AC [n = 805] (%)

Surgery-only [n = 316] (%)

p value

AC [n = 632] (%)

Surgery-only [n = 316] (%)

p value

Age

  

0.002

  

1.000

 < 60

415 (51.6)

130 (41.1)

 

260 (41.1)

130 (41.1)

 

 ≧ 60

390 (48.4)

186 (58.9)

 

372 (58.9)

186 (58.9)

 

Sex

  

0.102

  

0.255

 Male

567 (70.4)

238 (75.3)

 

454 (71.8)

238 (75.3)

 

 Female

238 (29.6)

78 (24.7)

 

178 (28.2)

78 (24.7)

 

Tumor location

  

0.143

  

0.296

 Upper

236 (29.3)

106 (33.5)

 

201 (31.8)

106 (33.5)

 

 Middle

139 (17.3)

44 (24.0)

 

105 (16.6)

44 (13.9)

 

 Lower

383 (47.6)

155 (49.1)

 

290 (45.9)

155 (49.1)

 

 Linitis plastica

47 (5.8)

11 (3.5)

 

36 (5.7)

11 (3.5)

 

Tumor size

  

0.638

  

0.849

 < 5 cm

519 (64.5)

199 (63.0)

 

402 (63.6)

199 (63.0)

 

≧ 5 cm

286 (35.5)

117 (37.0)

 

230 (36.4)

177 (37.0)

 

SCA

  

0.007

  

0.038

 Yes

145 (18.0)

36 (11.4)

 

104 (16.5)

36 (11.4)

 

 No

660 (82.0)

280 (88.6)

 

528 (83.5)

280 (88.6)

 

MCA

  

0.193

  

0.240

 Yes

69 (8.6)

35 (11.1)

 

55 (8.7)

35 (11.1)

 

 No

736 (91.4)

281 (88.9)

 

577 (91.3)

281 (88.9)

 

CA199 (U/ml)

  

0.623

  

0.436

 < 37

710 (88.2)

282 (89.2)

 

553 (87.5)

282 (89.2)

 

≧ 37

95 (11.8)

34 (10.8)

 

79 (12.5)

34 (10.8)

 

CEA (ng/ml)

  

0.627

  

0.951

 < 5

677 (84.1)

262 (82.9)

 

525 (83.1)

262 (82.9)

 

≧ 5

128 (15.9)

54 (17.1)

 

107 (16.9)

54 (17.1)

 

HB (g/L)

  

0.297

  

0.166

 < 120

289 (35.9)

124 (39.2)

 

219 (34.7)

124 (39.2)

 

≧ 120

516 (64.1)

192 (60.8)

 

413 (65.3)

192 (60.8)

 

T stage

  

0.086

  

0.088

 T1/2/3

665 (82.6)

247 (78.2)

 

523 (82.8)

247 (78.2)

 

 T4

140 (17.4)

69 (21.8)

 

109 (17.2)

69 (21.8)

 

N stage

  

0.141

  

0.215

 Positive

424 (52.7)

151 (47.8)

 

329 (52.1)

151 (47.8)

 

 Negative

381 (47.3)

165 (52.2)

 

303 (47.9)

165 (52.2)

 
  1. SCA, signet ring cell carcinoma; MCA, mucinous adenocarcinoma; CEA, carcinoembryonic antigen; CA199, carbohydrate antigen 19-9